• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older.

作者信息

Chicharro-Molero J A, Burgos-Rodriguez R, Sanchez-Cruz J J, del Rosal-Samaniego J M, Rodero-Carcia P, Rodriguez-Vallejo J M

机构信息

Department of Urology, Hospital Carlos Haya, Málaga, Spain.

出版信息

J Urol. 1998 Mar;159(3):878-82. doi: 10.1097/00005392-199803000-00072.

DOI:10.1097/00005392-199803000-00072
PMID:9474174
Abstract

PURPOSE

We estimate the prevalence of benign prostatic hyperplasia (BPH) according to symptoms as well as prostate obstruction determined by uroflowmetry and prostate size.

MATERIALS AND METHODS

A cross-sectional study was performed at the autonomous community of Andalusia in 1,106 men 40 years old or older. The International Prostate Symptom Score (I-PSS) questionnaire was used to establish symptoms, abdominal and transrectal ultrasonography was done to measure prostate size and uroflowmetry was performed to measure urinary flow obstruction.

RESULTS

The prevalence of moderate or severe symptoms was 24.94% and it increased with age. Of the 1,106 subjects 4.19% had severe prostatism, while 12.45% had poor quality of life (I-PSS greater than 3). Average prostate size was greater than 30 gm. in men 60 years old or older. Maximum urine flow was less than 10 and 15 ml. per second in 25.97 and 55.67% of the men, respectively. The prevalence of BPH, defined as I-PSS greater than 7, maximum flow less than 15 ml. per second and prostate size greater than 30 gm., was 11.77% (range 0.75 to 30 at ages 40 to 49 and greater than 70 years, respectively).

CONCLUSIONS

The prevalence of BPH increases with age. Moderate prostatism is perceived as resulting in poor quality of life by young subjects and good quality of life by some older subjects. In some men there were symptoms and obstruction but no prostate enlargement. This percentage persists with age after 50 years, when the prevalence of BPH starts to increase.

摘要

相似文献

1
Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older.
J Urol. 1998 Mar;159(3):878-82. doi: 10.1097/00005392-199803000-00072.
2
Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older.基于人群的伊朗40岁及以上男性良性前列腺增生患病率研究。
Int Urol Nephrol. 2008;40(4):921-31. doi: 10.1007/s11255-008-9338-7. Epub 2008 Feb 2.
3
High prevalence of benign prostatic hypertrophy in the community.
Lancet. 1991 Aug 24;338(8765):469-71. doi: 10.1016/0140-6736(91)90543-x.
4
Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate.前列腺增生症的自然病史:症状、前列腺体积与最大尿流率之间的关系。
J Urol. 1995 May;153(5):1510-5. doi: 10.1016/s0022-5347(01)67448-2.
5
Prostatic enlargement, symptomatology and pressure/flow evaluation: interrelations in patients with symptomatic BPH.
Scand J Urol Nephrol Suppl. 1994;157:67-73.
6
Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.移行区指数作为评估良性前列腺增生的一种方法:与症状、尿流及逼尿肌压力的相关性
J Urol. 1995 Nov;154(5):1764-9.
7
Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms.症状评分、流速和前列腺体积相结合用于预测男性下尿路症状患者的膀胱出口梗阻。
J Urol. 2000 Aug;164(2):344-8.
8
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素:克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
9
Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.国际前列腺症状评分与压力-流率研究在有症状良性前列腺增生评估中的相关性
J Urol. 1996 Jan;155(1):200-2. doi: 10.1097/00005392-199601000-00072.
10
Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.韩国农村地区良性前列腺增生患病率的社区研究。
Korean J Urol. 2015 Jan;56(1):68-75. doi: 10.4111/kju.2015.56.1.68. Epub 2015 Jan 12.

引用本文的文献

1
Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil.对接受5-α还原酶抑制剂治疗的良性前列腺增生男性患者的前列腺特异性抗原监测:西班牙和巴西泌尿外科医生真实临床实践的非干预性横断面研究
BMC Urol. 2025 Jan 31;25(1):22. doi: 10.1186/s12894-025-01701-1.
2
Benefits and advances of Cone Beam CT use in prostatic artery embolization: review of the literature and pictorial essay.锥形束CT在前列腺动脉栓塞术中应用的益处与进展:文献综述及图像分析
CVIR Endovasc. 2024 May 15;7(1):46. doi: 10.1186/s42155-024-00459-1.
3
A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.
植物甾醇强化型和常规锯棕榈油缓解良性前列腺增生和雄激素缺乏的双盲、安慰剂对照随机比较研究。
BMC Urol. 2020 Jul 3;20(1):86. doi: 10.1186/s12894-020-00648-9.
4
The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis.全球下尿路症状(良性前列腺增生症的提示)负担:系统评价和荟萃分析。
Sci Rep. 2017 Aug 11;7(1):7984. doi: 10.1038/s41598-017-06628-8.
5
Epidemiology of lower urinary tract symptoms: emphasis on the status in Korea.下尿路症状的流行病学:聚焦韩国的现状
Korean J Urol. 2014 May;55(5):300-8. doi: 10.4111/kju.2014.55.5.300. Epub 2014 May 12.
6
Effects of the chronic use of finasteride and doxazosin mesylate on the histomorphometric characteristics of the prostate: experimental study in rats.非那雄胺和甲磺酸多沙唑嗪慢性应用对前列腺组织形态计量学特征的影响:大鼠实验研究。
Int Urol Nephrol. 2011 Mar;43(1):39-45. doi: 10.1007/s11255-010-9770-3. Epub 2010 Jun 8.
7
Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?撒哈拉以南非洲地区的代谢综合征:该地区前列腺疾病的“小孪生兄弟”?
Int Urol Nephrol. 2008;40(4):909-20. doi: 10.1007/s11255-008-9343-x. Epub 2008 Feb 21.
8
Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older.基于人群的伊朗40岁及以上男性良性前列腺增生患病率研究。
Int Urol Nephrol. 2008;40(4):921-31. doi: 10.1007/s11255-008-9338-7. Epub 2008 Feb 2.
9
Doxazosin added to single-drug therapy in hypertensive patients with benign prostatic hypertrophy.多沙唑嗪添加到患有良性前列腺增生的高血压患者的单药治疗中。
J Clin Hypertens (Greenwich). 2001 Jul-Aug;3(4):218-23. doi: 10.1111/j.1524-6175.2001.00459.x.
10
The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.奥地利男性下尿路症状的患病率及其与社会人口统计学变量的关联。
Eur J Epidemiol. 1999 Sep;15(8):717-22. doi: 10.1023/a:1007605826026.